Last reviewed · How we verify
Visine Dry Eye Relief eye drops
Visine Dry Eye Relief lubricates and protects the ocular surface by providing artificial tears to supplement insufficient natural tear production.
Visine Dry Eye Relief lubricates and protects the ocular surface by providing artificial tears to supplement insufficient natural tear production. Used for Dry eye syndrome / dry eye disease.
At a glance
| Generic name | Visine Dry Eye Relief eye drops |
|---|---|
| Sponsor | Massachusetts Eye and Ear Infirmary |
| Drug class | Artificial tear lubricant |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
The eye drops contain lubricating agents (typically polyethylene glycol and propylene glycol) that coat the cornea and conjunctiva, reducing friction and irritation associated with dry eye. By maintaining a protective tear film, the drops alleviate symptoms of dryness, grittiness, and discomfort while promoting corneal health.
Approved indications
- Dry eye syndrome / dry eye disease
Common side effects
- Temporary blurred vision
- Eye irritation or stinging
- Allergic reaction (rare)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Visine Dry Eye Relief eye drops CI brief — competitive landscape report
- Visine Dry Eye Relief eye drops updates RSS · CI watch RSS
- Massachusetts Eye and Ear Infirmary portfolio CI